Spectrum News: Doctors explain high COVID-19 death rate despite high vaccination rate
UC expert says a nationwide failure to collaborate is a facdtor
The United States recently reached the one million mark in COVID-19 deaths, despite having a higher than average vaccination rate. While most masking and social distancing restrictions have been eased up in the past few months, the pandemic remains ongoing and in some areas, shows signs of worsening. Medical professionals have a variety of theories of why the pandemic is staying with us.
In a story produced by Spectrum News, one of the experts interviewed was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
Fichtenbaum told Spectrun News he believes a contributing factor was the unwillingness to work together as a country to flatten the curve.
“When you’re not really willing to listen, agree and collaborate and look at the information at hand and decide what’s the best course of action,” Fichtenbaum said.
Fichtenbaum said medical professionals have estimated, thanks to the vaccine, about one million American lives were saved, but because only two-thirds of Americans have gotten fully vaccinated, there was never a chance that it could end the pandemic.
“What we’ve realized is if we can’t get coverage wide enough, a vaccine alone is not going to be good enough to stop or end a pandemic,” Fichtenbaum said.
The pandemic also put a lot of things on pause, like routine doctor visits and staying active and eating healthy.
Lead photo/Colleen Kelley/UC Creative + Brand.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
$15 million bequest supports endowed chair at UC College of Medicine
May 19, 2026
As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.